Deutsche Bank
AXN

Deutsche Bank’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Deutsche Bank’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-258
Closed – – 5417
2016
Q2 		$0 Hold
258
– – ﹤0.01% 5474
2016
Q1 		$0 Sell
258
-4,700
-95% -$3.47K ﹤0.01% 5465
2015
Q4 		$3K Sell
4,958
-10,742
-68% -$13.5K ﹤0.01% 5124
2015
Q3 		$23K Buy
+15,700
New +$24.7K ﹤0.01% 4746
2015
Q2 		– Sell
-78
Closed – – 5563
2015
Q1 		$0 Buy
+78
New +$73 ﹤0.01% 6305

Other funds holding AXN

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank's AXN Position: Q3 2016 in Review

Deutsche Bank sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q3 2016, closing a stake of 258 shares.

Deutsche Bank first reported a position in AXN in Q1 2015 and held it in 5 quarters. The position peaked at $23K in Q3 2015. 12 funds tracked by Wall St. Rank hold AXN as of Q3 2016.

  • Deutsche Bank reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q3 2016 after selling out during the quarter.
  • Deutsche Bank sold 258 Aoxing Pharmaceutical Company Inc. shares in Q3 2016.
  • Deutsche Bank first reported a position in Aoxing Pharmaceutical Company Inc. in Q1 2015 and held it in 5 quarters.
  • Deutsche Bank's Aoxing Pharmaceutical Company Inc. position peaked at $23K in Q3 2015.
  • 12 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.